Amoy Diagnostics Co., Ltd. (AmoyDx) focuses on molecular diagnostics for oncology precision medicine. With completely independent intellectual property rights of ADx-ARMS and Super-ARMS technologies, AmoyDx has a market-leading portfolio of molecular diagnostic kits including but not limited to EGFR, RAS, ALK, BRAF, PIK3CA and ROS1 testing kit, which were firstly approved by CFDA and CE certified. In European EMQN and Chinese PQCC programs, AmoyDx is the NO.1 testing kits supplier for some years and always achieves the highest accuracy rate. Nowadays AmoyDx serves an extensive domestic and international oncology network reaching over 300 hospitals in China and 50 countries all over the world. Every year hundreds of thousands of cancer patients are benefitted from AmoyDx products. AmoyDx is strategic partner of AstraZeneca, Boehringer-Ingelheim, Pfizer, Merck and Illumina, providing diagnostic products and services for medicine development and clinical studies in gene tissue and blood testing. AmoyDx ROS1 kit was recently approved by Japanese authority PMDA as the sole companion diagnostic kit for Pfizer's crizotinib, which became the 1st approved CDx kit in the world for lung cancer patients' ROS1 testing.
View Top Employees from AmoyDxWebsite | http://www.amoydx.com |
Revenue | $2.4 million |
Employees | 1 (1 on RocketReach) |
Address | 39 Dingshan Rd, Xiamen, Anhui, CN |
Phone | +86 592 680 6835 |
Industry | Medical Testing & Clinical Laboratories, Healthcare |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular AmoyDx employee's phone or email?
The AmoyDx annual revenue was $2.4 million in 2023.
1 people are employed at AmoyDx.
AmoyDx is based in Xiamen, Anhui.
The NAICS codes for AmoyDx are [3254, 32541, 32, 325].
The SIC codes for AmoyDx are [283, 28].